FDA science freaks deciding which harmless Covid strain to address with a NEW DEADLY clot shot BOOSTER
- A key FDA advisory committee (VRBPAC) unanimously voted to approve updated COVID-19 boosters targeting the Omicron JN.1 strain for the 2025-2026 season, despite concerns over transparency and lack of safety data.
- Critics, including epidemiologists and public health advocates, highlighted the absence of safety data in presentations by Pfizer, Moderna, Novavax and the CDC. Some called for mRNA vaccines to be withdrawn, citing VAERS reports of 19,400 post-vaccination deaths.
- The committee chose JN.1 due to its dominance, including subvariants KP.2 and LP8.1 (now 70% of U.S. cases). No vote was taken on narrowing the focus to LP.8.1 specifically.
- WHO and FDA officials acknowledged that JN.1 boosters provide only relative protection (3–4 months) for those with prior immunity. The FDA also plans to restrict future approvals to high-risk groups, raising concerns about insurance coverage.
- Scientists and advocates demanded stronger safety reviews, public engagement, and oversight, questioning the FDA’s push for annual boosters amid unresolved efficacy and risk concerns.
The vaccine bioweapon depopulation program and freakshow continues. That’s right folks, 5 deadly clot shots is not enough, because there are new strains of Fauci Flu still swarming around the atmosphere in microscopic spit particles from Fauci when he was talking without his mask on at baseball games. Beware. The Food and Drug Adulteration Agency is hard at work playing pin the tail on the donkey, blindfolded, trying to decide which strain of Covid they’ll say is SO DEADLY that children, babies, and pregnant women need to get jabbed with immediately to survive.
Which strain will it be? The Biden-Delta-2025? The JN.1? Is the Bill-Gates-KP.2 and LP8.1 subvariants? The Fauci-Omega-Bird-Cat-Human GOF variant? Will Trump employ the Warp-Speed communists at the Wuhan lab or some rogue Biotech shills at University of North Carolina? Who will make the next deadly jab for the deadliest strain of Covid the world has ever seen? Fake news, get ready.
FDA advisers unanimously recommend JN.1-targeted COVID-19 boosters amid safety concerns
A key FDA advisory panel voted unanimously Thursday to recommend updated COVID-19 booster shots targeting the Omicron JN.1 strain for the 2025-2026 season, despite concerns over transparency and a lack of safety data. The Vaccines and Related
Biological Products Advisory Committee (VRBPAC) concluded that the JN.1-based formula—already used in last year’s shots—would provide three to four months of enhanced protection for those with prior immunity. The decision aligns with recent World Health Organization (WHO) guidance but follows mounting criticism over the FDA’s approval process and calls to pull existing mRNA vaccines from the market.
The VRBPAC meeting, the first under the current administration, centered on selecting the most effective viral strain for next year’s boosters. Dr. Vinay Prasad, the FDA’s new director of the Center for Biologics Evaluation and Research, emphasized the need for “open and transparent discussion” but acknowledged gaps in public engagement. The committee opted for a JN.1 vaccine, vaccine, citing its dominance over the past year, including its KP.2 and LP8.1 subvariants. However, no vote was taken on whether to narrow the focus to LP8.1, which now accounts for 70% of U.S. cases.
Critics, including epidemiologist Dr. Meryl Nass, noted the absence of safety data in presentations by Pfizer, Moderna, Novavax, and the CDC. “Not a single presentation actually mentioned safety data. This is entirely unacceptable,” Nass wrote during the meeting. Meanwhile, public commenters like Dr. Brian Hooker of Children’s Health Defense urged the FDA to withdraw mRNA vaccines entirely, citing VAERS reports of 19,400 deaths post-COVID vaccination—far exceeding historical flu vaccine fatalities. “The swine flu vaccine was pulled for just 50 deaths—what are you waiting for?” Hooker asked.
The meeting occurred days after the FDA announced plans to restrict future COVID vaccine approvals to high-risk groups—a move some fear could limit insurance coverage. Committee Chair Dr. Arnold Monto pressed for VRBPAC input on the new framework, but FDA officials deferred further discussion. Dr. Kanta Subbarao of the WHO reiterated that JN.1 boosters offer relative, not absolute, protection, lasting only a few months.
The FDA’s push for annual COVID boosters faces growing scrutiny as scientists and advocates demand stronger safety reviews and accountability. While the JN.1 recommendation advances the agency’s goal of streamlining vaccinations, unresolved questions about efficacy, equity, and risk leave the public awaiting clearer answers—and more rigorous oversight.
Don't forget, Fauci and Biden got 5 Covid jabs plus boosters and still caught Covid multiple times. No wonder Biden has prostate cancer - the spike proteins must have traveled there. What a shame. Bookmark
Vaccines.news to your favorite independent websites for updates on experimental gene therapy BOOSTER injections that lead to turbo cancer and
Long-Vax-Syndrome.
Sources for this article include:
Pandemic.news
NaturalNews.com
ChildrensHealthDefense.org